Jaye L. Thompson
Chief Tech/Sci/R&D Officer at GREENWICH LIFESCIENCES, INC.
Net worth: 5 M $ as of 2024-03-30
Profile
Jaye L.
Thompson is the founder of Synergos, Inc. (founded in 1991) and Proxima Clinical Research, Inc. (founded in 2017).
Dr. Thompson's current job is Director at Gulf Coast Regional Center of Innovation & Commercialization since 2013.
Dr. Thompson is also currently Vice President-Clinical & Regulatory Affairs at Greenwich LifeSciences, Inc. since 2019.
Dr. Thompson's former jobs include Senior Vice President-Clinical & Regulatory at Repros Therapeutics, Inc. from 2013 to 2017, SVP-Clinical Development & Regulatory Affairs at Opexa Therapeutics, Inc. from 2009 to 2013, Advisor at MediGen Group LLC, and SVP-Regulatory Affairs & Emerging Biotechnologies at inVentiv Clinical Solutions LLC in 2009.
Dr. Thompson's education includes an undergraduate degree from Texas A&M University and graduate and doctorate degrees from Texas University of Health Center at San Antonio.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-10-26 | 260,348 ( 2.03% ) | 5 M $ | 2024-03-30 |
Jaye L. Thompson active positions
| Companies | Position | Start |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2019-08-31 |
| Gulf Coast Regional Center of Innovation & Commercialization | Director/Board Member | - |
Former positions of Jaye L. Thompson
| Companies | Position | End |
|---|---|---|
| REPROS THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | - |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Chief Tech/Sci/R&D Officer | 2013-03-31 |
| inVentiv Clinical Solutions LLC | General Counsel | 2008-12-31 |
Proxima Clinical Research, Inc.
 Proxima Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Proxima Clinical Research, Inc. is a contract research organization that provides regulatory and clinical research expertise to life sciences companies of all sizes and stages. The private company is based in Houston, TX, within the Texas Medical Center, the largest medical center in the world. Proxima CRO partners with medical device, pharmaceutical, biotechnology, and diagnostic firms across 18 countries and five continents to further advance the $130 billion industry. The company was founded by Kevin Coker, Jaye L. Thompson, Larry Wayne Lawson, and Kevin Coker has been the CEO since incorporation. | Founder | - |
Synergos, Inc.
 Synergos, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., Synergos, Inc. provides clinical trial management services. The private company is based in The Woodlands, TX. The company was founded by Jaye L. Thompson. Synergos was acquired by Ventiv Health, Inc. on April 05, 2006 for $5.75 million. | Founder | - |
Training of Jaye L. Thompson
| Texas A&M University | Undergraduate Degree |
| Texas University of Health Center at San Antonio | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Synergos, Inc.
Synergos, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., Synergos, Inc. provides clinical trial management services. The private company is based in The Woodlands, TX. The company was founded by Jaye L. Thompson. Synergos was acquired by Ventiv Health, Inc. on April 05, 2006 for $5.75 million. | Commercial Services |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
MediGen Group LLC
 MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas | Finance |
| inVentiv Clinical Solutions LLC | |
| Gulf Coast Regional Center of Innovation & Commercialization | |
Proxima Clinical Research, Inc.
Proxima Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Proxima Clinical Research, Inc. is a contract research organization that provides regulatory and clinical research expertise to life sciences companies of all sizes and stages. The private company is based in Houston, TX, within the Texas Medical Center, the largest medical center in the world. Proxima CRO partners with medical device, pharmaceutical, biotechnology, and diagnostic firms across 18 countries and five continents to further advance the $130 billion industry. The company was founded by Kevin Coker, Jaye L. Thompson, Larry Wayne Lawson, and Kevin Coker has been the CEO since incorporation. | Commercial Services |
| Greenwich LifeSciences, Inc. |
- Stock Market
- Insiders
- Jaye L. Thompson
